tiprankstipranks
Trending News
More News >
Nulab Inc. (JP:5033)
:5033
Japanese Market
Advertisement

Nulab Inc. (5033) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Nulab Inc.

(5033)

Rating:75Outperform
Price Target:
¥1,035.00
▲(16.95%Upside)
Nulab Inc. achieves a strong overall score driven by its excellent financial performance and attractive valuation. The company's solid revenue growth and profitability improvements are key strengths. However, mixed technical indicators suggest caution in the short term. The absence of notable earnings call insights or corporate events slightly limits the overall analysis.

Nulab Inc. (5033) vs. iShares MSCI Japan ETF (EWJ)

Nulab Inc. Business Overview & Revenue Model

Company DescriptionNulab Inc. (5033) is a technology company focused on developing collaborative software solutions that enhance team productivity and communication. The company operates primarily in the software-as-a-service (SaaS) sector, offering a suite of products designed to streamline project management, facilitate team collaboration, and improve workflow efficiency. Nulab's core products include tools such as Backlog, a project management and bug tracking tool; Cacoo, a diagramming application; and Typetalk, a team chat application.
How the Company Makes MoneyNulab Inc. generates revenue primarily through its subscription-based model, where customers pay for access to its software solutions on a monthly or annual basis. The company offers tiered pricing plans for its products, allowing customers to choose packages based on the number of users and the level of functionality required. This subscription model ensures a steady stream of recurring revenue. Additionally, Nulab may engage in enterprise partnerships, providing customized solutions and services to larger organizations, which can contribute significantly to its earnings. The company also benefits from network effects, as more users and teams adopting its tools can lead to increased visibility and market penetration.

Nulab Inc. Financial Statement Overview

Summary
Nulab Inc. exhibits robust financial health with strong revenue growth, improved profitability, and an efficient cost structure. The balance sheet shows prudent leverage management and a strong capital structure, while cash flow generation remains solid despite a slight decrease in operating cash flow.
Income Statement
85
Very Positive
Nulab Inc. demonstrates strong revenue growth with a significant increase from the previous year. The gross profit margin is healthy at approximately 72%, indicating efficient cost management. Net profit margin has improved, reflecting higher profitability. Additionally, the company shows strong EBIT and EBITDA margins, which suggest robust operational performance.
Balance Sheet
78
Positive
The company's balance sheet reflects a very low debt-to-equity ratio, signifying prudent leverage management. Return on equity is strong, indicating efficient use of shareholder funds. The equity ratio is solid, suggesting a strong capital structure with an emphasis on equity financing over debt.
Cash Flow
80
Positive
Nulab Inc. has a strong cash flow position with consistent operating cash flow growth. The free cash flow to net income ratio is favorable, indicating good cash generation relative to reported profits. However, a slight decrease in operating cash flow from the previous year suggests a need for caution.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue4.04B4.11B3.66B2.71B2.33B1.94B
Gross Profit2.87B2.96B2.64B1.73B1.42B1.09B
EBITDA532.46M753.00M424.12M179.14M266.01M66.69M
Net Income340.84M552.68M308.16M88.42M197.88M-25.53M
Balance Sheet
Total Assets3.93B4.24B3.47B2.61B1.62B1.33B
Cash, Cash Equivalents and Short-Term Investments3.25B3.13B2.48B1.74B1.13B878.98M
Total Debt3.00M2.25M5.25M13.75M58.69M154.21M
Total Liabilities2.19B2.34B2.14B1.65B1.23B1.15B
Stockholders Equity1.74B1.91B1.33B958.63M391.25M182.66M
Cash Flow
Free Cash Flow0.00724.95M694.57M169.40M321.29M153.73M
Operating Cash Flow0.00749.13M811.90M297.32M401.01M242.03M
Investing Cash Flow0.00-128.81M-110.72M-130.74M-74.35M-80.91M
Financing Cash Flow0.00-1.00M16.87M417.41M-95.27M-119.66M

Nulab Inc. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price885.00
Price Trends
50DMA
936.56
Negative
100DMA
963.44
Negative
200DMA
875.71
Positive
Market Momentum
MACD
-17.06
Negative
RSI
48.09
Neutral
STOCH
68.80
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5033, the sentiment is Neutral. The current price of 885 is below the 20-day moving average (MA) of 896.65, below the 50-day MA of 936.56, and above the 200-day MA of 875.71, indicating a neutral trend. The MACD of -17.06 indicates Negative momentum. The RSI at 48.09 is Neutral, neither overbought nor oversold. The STOCH value of 68.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:5033.

Nulab Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
¥5.84B12.60
1.18%15.30%14.43%
78
Outperform
¥6.53B22.71
29.19%
78
Outperform
¥4.79B10.26
1.22%59.60%353.05%
75
Outperform
¥5.74B10.45
12.27%78.43%
68
Neutral
¥5.69B31.83
17.25%
61
Neutral
CHF2.69B-66.47-3.96%2.60%-26.92%-138.40%
61
Neutral
¥5.40B39.93
1.85%2.76%-47.70%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:5033
Nulab Inc.
891.00
-94.00
-9.54%
JP:3653
Morpho, Inc.
1,211.00
-748.00
-38.18%
JP:4372
YMIRLINK,Inc.
1,558.00
284.85
22.37%
JP:4379
Photosynth inc.
371.00
-27.00
-6.78%
JP:4428
Sinops, Inc.
870.00
-376.34
-30.20%
JP:4440
WITZ Corp.
1,241.00
408.66
49.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 24, 2025